1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6C51D4CD90C8A47D900258CA00038993D
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-inside-medtech-compliance-organizational-models-strategic-drivers-regulatory-quality?opendocument
18
19opendocument
2018.97.9.172
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB
Access. Intelligence. Excellence

| Advanced Search | 0
Research and Consulting Areas of Expertise

Benchmarking Reports Areas of Expertise Report Catalog FAQ
Best Practice Database Areas of Expertise New Research Case Analogs Benefits Types Of Research Current Members
Research and Advisory Services Areas of Expertise Field Medical Excellence Medical Affairs Consortium White Papers Research Partners Partnership Benefits Contact Us
Excellence Services Field Medical Excellence (FME) Launch Services Excellence Patient Support Excellence Medical Operations Excellence Collections New Product Planning Medical Affairs

Industries

Biotechnology Financial Services Healthcare Medical Device Manufacturing Pharmaceuticals Technology and Communications

Functions

Brand Management & Product Leadership Competitive & Business Intelligence Commercial Operations Customer Service Clinical Operations Digital Technologies / AI Human Resources Medical Affairs Market Access Market Research, Analytics & Forecasting

 

Marketing Management Patient Access, Support, Insights and Operations Product Launch Pull Through Pharma Launch Playbook Scenario Planning / War Gaming Sales Supply Chain
Corporate Overview About Benchmarking Benchmarking Books What is a Best Practice? Research Methodology

Our Clients Testimonials

Our Team Careers Best Practices Interns Work at Best Practices, LLC Help Set Research Agenda
Follow Best Practices LLC linkedIn twitter slideshare youtube pinterest

Overview Press Releases Speaking Events Media Coverage Receive Research Updates Contact Us
Address/Email/Phone Schedule a Meeting
Report Catalog Videos
Database Member Home RAS Member Home

» Products & Services » » Quality, Compliance and Regulatory » Structure,Staffing and Execution

Inside MedTech Compliance: Organizational Models and Strategic Drivers in Regulatory and Quality

DB Image

Download FREE Excerpt

ID: 5878

Features:

8 Info Graphics

25 Data Graphics

270+ Metrics

Pages/Slides: 43

Published: 2025

Delivery Format: Online PDF Document

 

License Options:


Buy Now

 

919-403-0251
Schedule a Meeting
Request a Quote


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Inside MedTech Compliance: Organizational Models and Strategic Drivers in Regulatory and Quality”

STUDY OVERVIEW

As the MedTech landscape grows more complex and compliance pressures intensify, Regulatory and Quality (RAQA) teams must be more than process enforcers—they must be strategically structured to accelerate innovation, manage risk, and meet global obligations.

This study explores how business models, organizational structures, and oversight dynamics shape RAQA performance across emerging, mid-sized, and large MedTech firms. It analyzes critical drivers of compliance success — from portfolio mix and therapeutic scope to geographic footprint and the influence of consent decrees. This study also evaluates the impact of company size, product type, and regulatory history on structural choices and investment priorities.

Ideal for leaders redesigning their compliance models or benchmarking structural efficiency, this research offers a practical roadmap to building high-performing, future-ready RAQA organizations.


KEY TOPICS

  • Strategic compliance performance influencers
  • Impact of business size and portfolio complexity on compliance demands
  • RAQA organizational models
  • Impact of consent decrees on investment and focus

KEY METRICS

  • Ecosystem framework analyzing 15+ critical influencers on regulatory and quality performance
  • Segmentation of business units by organizational type (legacy and current perspectives)
  • Therapeutic area coverage – reach across clinical market segments
  • Annual revenue reporting – comparative insights from legacy and updated datasets
  • Revenue distribution by respondent – individual-level breakdowns
  • Product portfolio mix by regulatory classification – Class I, II, III comparisons over time
  • Portfolio breakdown by business focus – product share by strategic priority
  • Operating models for RAQA functions – current organizational structures
  • RAQA structure by company size – distinctions between large and mid/small organizations
  • RAQA alignment – regional vs. global approaches across participant organizations
  • Shared services deployment – prevalence and design of Centers of Excellence (CoE)
  • Benefits of shared services – efficiency gains and specialized support impact
  • Cost outcomes linked to shared service models
  • RAQA structure strengths and weaknesses – current and legacy perspectives
  • Involvement in consent decrees or corporate integrity agreements (CIA) – trend view
  • Investment shifts under CIA mandates – regulatory and quality budget impacts
  • Regulatory and quality investment trends under CIA conditions

SAMPLE KEY FINDINGS

  • Structure: RAQA structures evolve based on company size, global footprint, and portfolio complexity. Larger enterprises often combine RA and QA functions. Centers of Excellence are used to cost-effectively leverage RAQA expertise across regions.

METHODOLOGY

Best Practices, LLC benchmarked RAQA performance across 63 MedTech business units, drawing on data contributed across multiple time periods. The latest update features in-depth insights from 10 top organizations. Participants were segmented by product type—technology-enabled, robotics surgical, and traditional devices—as well as by company size and maturity, including emerging, mid-size, and large organizations.

Industries Profiled:
Medical Device; Health Care; Pharmaceutical; Diagnostic; Biopharmaceutical; High Tech; Biotech; Medical; Technology; Consulting; Science


Companies Profiled:
3M - DDSD; Abbott; Abbott Vascular; Accelerate Diagnostics; Acceleron Pharma; Aesculap; Agilent; Alcon; B. Braun; Baxter Healthcare; Beckman Coulter; BIOTRONIK; Boston Scientific; CMR Surgical Ltd; ConMed; Cook Medical; eNeura Therapeutics; Fisher & Paykel Healthcare; FzioMed; Getinge; GRIFOLS; Haemonetics Corporation; Halma; insStem; Johnson & Johnson; Lentigen Corporation; Lifecore Biomedical; Meril Life Sciences; Minnetronix Medical; Molnlycke Health Care; NeedleTech Products; neMedIO; nSpire Health; Onconova Therapeutics; Ortho Clinical Diagnostics; PerkinElmer; Philips; QMS Consulting; Quest Medical; Radius Health; ReShape Lifesciences; ResMed; Sartorius Stedim; Smith & Nephew; Stryker; Teleflex; Thermo Fisher Scientific; Verastem Oncology; Waters Corporation; Wright Medical; Zimmer Biomet; ZimVie

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

RELATED RESEARCH